Literature DB >> 17407623

Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another.

Ron Goeree1, Natasha Burke, Daria O'Reilly, Andrea Manca, Gord Blackhouse, Jean-Eric Tarride.   

Abstract

BACKGROUND: Geographic transferability of economic evaluation data from one country to another has the potential to make a more efficient use of national and international evaluation resources. However, inappropriate transferability of economic data can provide misleading results and lead to an inefficient use of scarce health care resources.
OBJECTIVES: The objective of this study was to review, summarize and categorize the literature on: (i) factors affecting the geographic transferability of economic evaluation data; and (ii) approaches which have either been proposed or used for transferability.
METHODS: A systematic literature review on transferability was conducted. Electronic databases, hand searching and bibliographic searching techniques were utilized. Inclusion criteria for the review included conceptual or empirical papers with mention of factors affecting, or approaches for, transferability of economic evaluation data across geographic locations. Exclusion criteria included papers published prior to 1966, non-English language papers, pure science studies and animal studies. Three databases were involved in the primary search: Ovid MEDLINE, EMBASE, and CINAHL. In addition to the primary search, the Heath Economic Evaluation Database (OHE HEED), the NHS EED database and the EconLit databases were searched. Transferability factors were classified into major and minor categories, a classification of alternative transferability approaches was developed, and the number of empirical studies was catalogued according to this classification.
RESULTS: There is a substantial amount of literature on factors potentially affecting transferability. Based on these papers we identified 77 factors and subsequently developed a classification system which grouped these factors into five broad categories based on characteristics of the patient, the disease, the provider, the health care system and methodological conventions. Another 40 studies were identified which attempted to transfer economic evaluation data from one country to another and these were classified according to the sources for clinical efficacy, resource utilization and unit cost data.
CONCLUSIONS: There is strong evidence indicating that transferability of economic evaluation data is a difficult and complex task. Approaches which have been used for transferability suggest that, at a minimum, there is a need for country-specific substitution of practice pattern data as well as unit cost data. A limitation of this review relates to the lack of empirical studies which prevents stronger conclusions regarding which transferability factors are most important to consider and under which circumstances.

Entities:  

Mesh:

Year:  2007        PMID: 17407623     DOI: 10.1185/030079906x167327

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  40 in total

1.  Conceptual framework for standard economic evaluation of physical activity programs in primary prevention.

Authors:  Silke B Wolfenstetter
Journal:  Prev Sci       Date:  2011-12

Review 2.  Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.

Authors:  Patricia R Blank; Konstantin J Dedes; Thomas D Szucs
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 3.  A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

Authors:  Wendy L St. Peter; Lori D Wazny; Eric Weinhandl; Katie E Cardone; Joanna Q Hudson
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

Review 4.  Economic Evaluation of Quality Improvement Interventions Designed to Prevent Hospital Readmission: A Systematic Review and Meta-analysis.

Authors:  Teryl K Nuckols; Emmett Keeler; Sally Morton; Laura Anderson; Brian J Doyle; Joshua Pevnick; Marika Booth; Roberta Shanman; Aziza Arifkhanova; Paul Shekelle
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

5.  Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable?

Authors:  Saskia Knies; Math J J M Candel; Annelies Boonen; Silvia M A A Evers; Andre J H A Ament; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2012-09-01       Impact factor: 4.981

6.  [Drug treatment of cystic fibrosis - cost patterns and savings potential for outpatient treatment].

Authors:  Christoph T Baltin; Christina Smaczny; Thomas O Wagner
Journal:  Med Klin (Munich)       Date:  2011-01-16

7.  The opportunities for and obstacles against prevention: the example of Germany in the areas of tobacco and alcohol.

Authors:  Ulla Walter; Marc Suhrcke; Miriam G Gerlich; Till A Boluarte
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

8.  Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index.

Authors:  Adrian Gheorghe; Tracy Roberts; Karla Hemming; Melanie Calvert
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

Review 9.  Economic Evaluation of Quality Improvement Interventions for Bloodstream Infections Related to Central Catheters: A Systematic Review.

Authors:  Teryl K Nuckols; Emmett Keeler; Sally C Morton; Laura Anderson; Brian Doyle; Marika Booth; Roberta Shanman; Jonathan Grein; Paul Shekelle
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

Review 10.  Cost transferability problems in economic evaluation as a framework for an European health care and social costs database.

Authors:  Leticia García-Mochón; Joan Rovira Forns; Jaime Espin
Journal:  Cost Eff Resour Alloc       Date:  2021-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.